Rising Drug Costs Force a Third of Americans to Leave Prescriptions Unfilled: Report

Seeking Alpha03:44

AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy

Yahoo FinanceJun 28 22:00

AbbVie, Genmab Blood Cancer Therapy Endorsed in EU

Seeking AlphaJun 28 21:29

AbbVie (ABBV.US) has reached a $250 million acquisition agreement and obtained a potential first-in-class therapy.

Recently, AbbVie (ABBV.US) announced the acquisition of Celsius Therapeutics for a total consideration of USD 250 million.

Zhitong FinanceJun 28 21:09

AbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD Presence

Yahoo FinanceJun 28 20:51

AbbVie Completes Acquisition of Celsius Therapeutics for $250m

Yahoo FinanceJun 28 16:12